NCT07161193 Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Autoimmune Diseases Status NOT_YET_RECRUITING Phase PHASE1/PHASE2
NCT07159893 Inectolizumab With Steroid Optimization in Newly Treated NMOSD Status NOT_YET_RECRUITING Phase NA
NCT07122076 GT719 Injection for Moderate to Severe Refractory Autoimmune Diseases Status RECRUITING Phase EARLY_PHASE1
NCT07040917 A Study of CAR-T Cells in Subjects With Autoimmune Diseases Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT07040774 Natural History of Type 1 Interferonopathies: Insights From a European Cohort Status RECRUITING Phase N/A
NCT06976151 Effect of Transcutaneous Electrical Acupoint Stimulation on Dysmenorrhea Among Autoimmune Disease Women Status COMPLETED Phase NA
NCT06964269 Use of Acthar Gel Single-Dose Pre-Filled SelfJectTM Injector in Patients With Moderate-Severe Keratitis and Autoimmune Disease Status RECRUITING Phase PHASE4
NCT06940869 Network to Understand Reproductive Rheumatology Registry Status ENROLLING_BY_INVITATION Phase N/A
NCT06887985 JY231(JY231) Injection for the Treatment of Refractory Autoimmune Diseases (ADs) Status NOT_YET_RECRUITING Phase NA
NCT06872294 Research of Predictive Factors of in Vitro Fertilization (IVF) Outcome AI-IVF Study Status RECRUITING Phase N/A
NCT06827587 Efficacy and Safety of Efgartigimod Sequential Therapy with Telitacicept in Generalized Myasthenia Gravis Status NOT_YET_RECRUITING Phase NA
NCT06824896 A Post-marketing Observational Database Study Monitoring the Safety of CecolinⓇ Status COMPLETED Phase N/A
NCT06797375 Safety, Tolerability, Pharmacokinetics and Pharmacodynamics Study of RLYB116 in Healthy Participants Status COMPLETED Phase PHASE1
NCT06792799 Anti-CD19/BCMA CAR-NK Cells in Patients With B Cell Mediated Autoimmune Disease Status RECRUITING Phase EARLY_PHASE1